| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 36415 |
|
28,046 |
24,320 |
$4.63M |
| 80053 |
|
46,218 |
36,382 |
$4.28M |
| 97110 |
|
27,730 |
8,489 |
$2.11M |
| 97530 |
|
30,959 |
9,425 |
$1.96M |
| 96413 |
|
2,661 |
1,136 |
$1.78M |
| 96372 |
|
13,273 |
8,272 |
$1.70M |
| 96367 |
|
3,100 |
1,454 |
$1.69M |
| 96361 |
|
13,709 |
10,016 |
$1.60M |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,722 |
1,734 |
$1.43M |
| 92507 |
|
34,725 |
10,288 |
$1.34M |
| 96365 |
|
9,430 |
5,877 |
$1.06M |
| 0202U |
|
7,804 |
7,353 |
$707K |
| 99282 |
|
12,283 |
11,591 |
$688K |
| 96374 |
|
15,277 |
11,727 |
$603K |
| 96360 |
|
3,349 |
2,826 |
$526K |
| 99283 |
|
25,259 |
23,460 |
$504K |
| 88305 |
|
2,691 |
2,317 |
$481K |
| 11042 |
|
1,614 |
794 |
$423K |
| 81025 |
|
12,789 |
11,262 |
$415K |
| 87070 |
|
1,821 |
1,563 |
$389K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,886 |
2,253 |
$380K |
| 87081 |
|
7,670 |
7,363 |
$327K |
| 93306 |
|
2,527 |
2,329 |
$320K |
| J3490 |
Unclassified drugs |
13,143 |
6,813 |
$282K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,534 |
1,389 |
$254K |
| 71260 |
|
2,184 |
2,021 |
$250K |
| 96375 |
|
15,480 |
10,910 |
$247K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
9,385 |
6,138 |
$227K |
| 72148 |
|
488 |
455 |
$201K |
| 74177 |
|
4,613 |
4,254 |
$169K |
| 99284 |
|
21,370 |
19,055 |
$164K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
373 |
334 |
$162K |
| 80048 |
|
5,699 |
4,076 |
$158K |
| 81001 |
|
29,463 |
25,304 |
$143K |
| 42820 |
|
74 |
74 |
$138K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
942 |
915 |
$133K |
| 93971 |
|
1,110 |
1,023 |
$132K |
| 87486 |
|
1,923 |
1,795 |
$131K |
| J1815 |
Injection, insulin, per 5 units |
261 |
183 |
$128K |
| 87491 |
|
5,912 |
5,620 |
$112K |
| 70450 |
|
4,380 |
4,029 |
$108K |
| 71046 |
|
6,710 |
6,236 |
$105K |
| 87086 |
|
8,165 |
7,422 |
$98K |
| 73630 |
|
2,050 |
1,923 |
$94K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
1,317 |
1,276 |
$90K |
| 97162 |
|
2,323 |
2,134 |
$89K |
| 73610 |
|
1,721 |
1,591 |
$86K |
| 73721 |
|
134 |
128 |
$83K |
| 87426 |
|
1,728 |
1,462 |
$82K |
| 76377 |
|
2,422 |
2,027 |
$81K |
| 74018 |
|
2,142 |
1,983 |
$79K |
| 77063 |
|
882 |
860 |
$77K |
| 93005 |
|
15,933 |
11,973 |
$76K |
| 0241U |
|
2,960 |
2,750 |
$75K |
| 92523 |
|
1,038 |
1,004 |
$73K |
| 84702 |
|
4,950 |
3,894 |
$67K |
| 85025 |
|
55,237 |
42,355 |
$65K |
| 74176 |
|
2,079 |
1,893 |
$65K |
| 73562 |
|
1,828 |
1,708 |
$64K |
| 87400 |
|
4,281 |
4,082 |
$64K |
| 73030 |
|
1,827 |
1,709 |
$61K |
| 71045 |
|
12,170 |
10,315 |
$60K |
| 72100 |
|
1,997 |
1,908 |
$58K |
| 73130 |
|
937 |
888 |
$55K |
| 78452 |
|
231 |
212 |
$55K |
| 99285 |
|
13,304 |
11,310 |
$53K |
| 84443 |
|
8,905 |
8,084 |
$52K |
| 76705 |
|
1,427 |
1,330 |
$52K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
416 |
365 |
$48K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,287 |
9,487 |
$46K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
6,276 |
5,290 |
$45K |
| 87804 |
|
1,946 |
1,822 |
$44K |
| 73560 |
|
1,044 |
978 |
$41K |
| G0378 |
Hospital observation service, per hour |
8,072 |
3,488 |
$41K |
| 83735 |
|
11,315 |
8,431 |
$40K |
| 73502 |
|
1,111 |
1,018 |
$38K |
| 86592 |
|
3,597 |
3,428 |
$37K |
| 87210 |
|
1,729 |
1,655 |
$35K |
| 73110 |
|
655 |
595 |
$32K |
| 93922 |
|
167 |
140 |
$31K |
| 88304 |
|
66 |
63 |
$31K |
| V2632 |
Posterior chamber intraocular lens |
18 |
14 |
$29K |
| 72040 |
|
705 |
675 |
$29K |
| 86885 |
|
3,282 |
2,925 |
$28K |
| 84484 |
|
13,043 |
7,998 |
$28K |
| 97166 |
|
379 |
352 |
$26K |
| 87880 |
|
8,420 |
8,118 |
$26K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
12 |
12 |
$23K |
| 76830 |
|
539 |
512 |
$23K |
| 76642 |
|
414 |
391 |
$22K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,304 |
1,595 |
$21K |
| 87150 |
|
1,387 |
1,359 |
$21K |
| 85730 |
|
5,885 |
5,002 |
$18K |
| 86140 |
|
17,509 |
15,135 |
$18K |
| 77066 |
Tomosynthesis, mammo |
195 |
180 |
$16K |
| 0002A |
|
450 |
434 |
$16K |
| 96366 |
|
3,856 |
2,109 |
$15K |
| 97116 |
|
792 |
411 |
$14K |
| S0028 |
Injection, famotidine, 20 mg |
2,858 |
2,048 |
$14K |
| 72141 |
|
34 |
31 |
$13K |
| 87077 |
|
1,610 |
1,405 |
$13K |
| 96376 |
|
5,228 |
2,614 |
$12K |
| 82553 |
|
8,166 |
5,294 |
$12K |
| 0001A |
|
323 |
319 |
$11K |
| J1756 |
Injection, iron sucrose, 1 mg |
379 |
159 |
$11K |
| 76815 |
|
545 |
462 |
$11K |
| 42830 |
|
25 |
25 |
$11K |
| 87040 |
|
3,994 |
2,268 |
$11K |
| 94760 |
|
2,982 |
1,290 |
$10K |
| 73140 |
|
104 |
96 |
$10K |
| 77067 |
|
1,294 |
1,263 |
$10K |
| 72170 |
|
498 |
452 |
$10K |
| 76816 |
|
121 |
111 |
$9K |
| 74022 |
|
601 |
548 |
$9K |
| 94640 |
|
6,426 |
3,801 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,123 |
5,591 |
$9K |
| 84145 |
|
2,507 |
2,097 |
$9K |
| 82728 |
|
2,757 |
2,473 |
$8K |
| 80061 |
|
6,723 |
6,356 |
$8K |
| 76770 |
|
130 |
126 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,708 |
6,737 |
$8K |
| 87420 |
|
107 |
106 |
$7K |
| 85018 |
|
2,154 |
1,815 |
$7K |
| 97164 |
|
275 |
264 |
$7K |
| 87661 |
|
3,641 |
3,474 |
$7K |
| 85610 |
|
6,528 |
5,507 |
$6K |
| 70551 |
|
14 |
14 |
$6K |
| 76801 |
|
1,021 |
778 |
$6K |
| 86900 |
|
2,640 |
2,312 |
$6K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
215 |
185 |
$6K |
| 69436 |
|
70 |
68 |
$6K |
| 92526 |
|
489 |
164 |
$6K |
| 83690 |
|
8,425 |
7,240 |
$6K |
| 12001 |
|
25 |
25 |
$6K |
| 83615 |
|
3,230 |
2,201 |
$6K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,677 |
3,473 |
$6K |
| 83021 |
|
1,851 |
1,721 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
4,508 |
3,470 |
$6K |
| 83036 |
|
6,316 |
5,883 |
$5K |
| 66984 |
|
32 |
25 |
$5K |
| 99281 |
|
62 |
59 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,353 |
4,606 |
$4K |
| 71250 |
|
58 |
54 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,201 |
2,999 |
$4K |
| 82607 |
|
2,007 |
1,844 |
$4K |
| 80069 |
|
473 |
379 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,133 |
2,465 |
$4K |
| 82330 |
|
351 |
282 |
$4K |
| 87651 |
|
442 |
435 |
$4K |
| 76805 |
|
25 |
25 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
1,351 |
747 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,157 |
1,461 |
$3K |
| 85378 |
|
2,307 |
2,074 |
$3K |
| 93880 |
|
13 |
13 |
$3K |
| 97140 |
|
980 |
450 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,054 |
767 |
$3K |
| 93970 |
|
33 |
30 |
$3K |
| 93017 |
|
385 |
350 |
$3K |
| 73590 |
|
131 |
118 |
$3K |
| 84439 |
|
4,255 |
3,947 |
$3K |
| 0071A |
|
72 |
72 |
$3K |
| 81220 |
|
356 |
314 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
605 |
440 |
$2K |
| 76856 |
|
79 |
78 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,438 |
3,648 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,250 |
1,739 |
$2K |
| 76817 |
|
890 |
733 |
$2K |
| 82043 |
|
1,672 |
1,580 |
$2K |
| 85044 |
|
3,416 |
2,210 |
$2K |
| 87075 |
|
597 |
498 |
$2K |
| 86901 |
|
2,637 |
2,311 |
$2K |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
763 |
665 |
$2K |
| 97165 |
|
27 |
27 |
$2K |
| 83540 |
|
2,604 |
2,354 |
$2K |
| 0072A |
|
44 |
44 |
$2K |
| 83880 |
|
3,146 |
2,613 |
$2K |
| 87591 |
|
5,896 |
5,603 |
$2K |
| 87633 |
|
1,901 |
1,778 |
$2K |
| 76536 |
|
26 |
25 |
$2K |
| 82550 |
|
2,789 |
1,675 |
$1K |
| 82950 |
|
1,523 |
1,483 |
$1K |
| 82570 |
|
927 |
850 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,208 |
620 |
$1K |
| 84156 |
|
1,179 |
954 |
$1K |
| 83605 |
|
3,522 |
2,669 |
$1K |
| 45380 |
|
51 |
41 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,190 |
912 |
$1K |
| 84100 |
|
739 |
515 |
$1K |
| 0003A |
|
41 |
41 |
$1K |
| 93976 |
|
550 |
496 |
$1K |
| 43235 |
|
14 |
12 |
$1K |
| 72125 |
|
1,236 |
1,167 |
$1K |
| 70486 |
|
29 |
27 |
$1K |
| 82306 |
|
2,238 |
2,119 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,554 |
1,113 |
$1K |
| 85014 |
|
2,216 |
1,889 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
30 |
30 |
$1K |
| 97168 |
|
12 |
12 |
$1K |
| 86803 |
|
1,529 |
1,456 |
$1K |
| 87581 |
|
1,917 |
1,793 |
$1K |
| 87635 |
|
57 |
56 |
$1K |
| 87798 |
|
1,940 |
1,807 |
$1K |
| 73080 |
|
14 |
12 |
$907.76 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,619 |
2,075 |
$849.14 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
66 |
41 |
$787.50 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,069 |
811 |
$784.10 |
| 59025 |
|
41 |
24 |
$677.60 |
| 86336 |
|
233 |
223 |
$649.54 |
| 77336 |
|
36 |
13 |
$569.95 |
| 82105 |
|
809 |
768 |
$568.92 |
| 73090 |
|
13 |
13 |
$560.70 |
| 84466 |
|
1,668 |
1,485 |
$555.99 |
| 97161 |
|
65 |
52 |
$537.35 |
| 84550 |
|
1,237 |
1,127 |
$515.20 |
| 87340 |
|
2,172 |
1,978 |
$489.64 |
| 87493 |
|
547 |
230 |
$480.16 |
| 72081 |
|
12 |
12 |
$444.60 |
| 76857 |
|
278 |
267 |
$348.14 |
| J2785 |
Injection, regadenoson, 0.1 mg |
203 |
181 |
$347.83 |
| 84703 |
|
210 |
202 |
$339.92 |
| 84146 |
|
27 |
27 |
$322.76 |
| 82272 |
|
12 |
12 |
$300.97 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
79 |
63 |
$296.71 |
| 73564 |
|
16 |
14 |
$292.02 |
| 85027 |
|
1,723 |
1,041 |
$245.61 |
| 97163 |
|
12 |
12 |
$235.47 |
| 87389 |
|
1,876 |
1,822 |
$227.31 |
| 87186 |
|
3,275 |
2,936 |
$224.48 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
16 |
12 |
$220.52 |
| 82746 |
|
479 |
448 |
$193.92 |
| 84163 |
|
100 |
93 |
$173.85 |
| 83874 |
|
6,771 |
5,116 |
$166.03 |
| 97167 |
|
18 |
13 |
$153.32 |
| 87045 |
|
18 |
13 |
$145.14 |
| Q0247 |
Injection, sotrovimab, 500 mg |
14 |
14 |
$120.01 |
| 80076 |
|
74 |
57 |
$107.93 |
| 86038 |
|
135 |
129 |
$95.15 |
| 86762 |
|
462 |
439 |
$52.81 |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
16 |
16 |
$34.50 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
721 |
592 |
$33.69 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
350 |
274 |
$21.89 |
| 82150 |
|
1,160 |
1,049 |
$15.21 |
| 87088 |
|
2,157 |
1,960 |
$10.65 |
| 85652 |
|
2,639 |
2,476 |
$10.08 |
| 82247 |
|
45 |
26 |
$8.68 |
| 82009 |
|
26 |
25 |
$8.46 |
| 86308 |
|
30 |
29 |
$6.80 |
| J3480 |
Injection, potassium chloride, per 2 meq |
477 |
194 |
$1.96 |
| 00731 |
|
58 |
53 |
$0.00 |
| 87806 |
|
2,213 |
2,074 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
215 |
207 |
$0.00 |
| 82805 |
|
296 |
221 |
$0.00 |
| 86696 |
|
30 |
24 |
$0.00 |
| 83970 |
|
152 |
142 |
$0.00 |
| 86708 |
|
15 |
14 |
$0.00 |
| 88312 |
|
35 |
32 |
$0.00 |
| 43239 |
|
193 |
168 |
$0.00 |
| 36600 |
|
25 |
12 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
88 |
60 |
$0.00 |
| 82947 |
|
53 |
40 |
$0.00 |
| 78815 |
|
12 |
12 |
$0.00 |
| 85041 |
|
287 |
264 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
98 |
42 |
$0.00 |
| 87641 |
|
15 |
12 |
$0.00 |
| 85007 |
|
31 |
25 |
$0.00 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
31 |
28 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
14 |
13 |
$0.00 |
| 10060 |
|
12 |
12 |
$0.00 |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
24 |
13 |
$0.00 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
14 |
12 |
$0.00 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
13 |
12 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
28 |
28 |
$0.00 |
| 99152 |
|
18 |
12 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
42 |
14 |
$0.00 |
| 82565 |
|
47 |
33 |
$0.00 |
| 90715 |
|
17 |
14 |
$0.00 |
| 84295 |
|
38 |
25 |
$0.00 |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
39 |
13 |
$0.00 |
| 80055 |
|
15 |
13 |
$0.00 |
| 82677 |
|
523 |
506 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
140 |
83 |
$0.00 |
| 83550 |
|
609 |
592 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,569 |
1,266 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
49 |
24 |
$0.00 |
| J1097 |
Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml |
18 |
14 |
$0.00 |
| 82435 |
|
15 |
13 |
$0.00 |
| 90471 |
|
16 |
13 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
98 |
74 |
$0.00 |
| 94761 |
|
76 |
48 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
172 |
129 |
$0.00 |
| 86695 |
|
64 |
49 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
14 |
12 |
$0.00 |
| 86430 |
|
15 |
14 |
$0.00 |
| 86706 |
|
15 |
14 |
$0.00 |
| 96368 |
|
39 |
24 |
$0.00 |
| 90686 |
|
28 |
25 |
$0.00 |
| 84132 |
|
58 |
41 |
$0.00 |
| 86704 |
|
14 |
13 |
$0.00 |
| 89220 |
|
42 |
40 |
$0.00 |
| 83520 |
|
22 |
14 |
$0.00 |
| 74019 |
|
12 |
12 |
$0.00 |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
16 |
12 |
$0.00 |
| 36430 |
|
12 |
12 |
$0.00 |
| 97112 |
|
31 |
14 |
$0.00 |
| 00813 |
|
19 |
15 |
$0.00 |